Back to search

Article

JAK/STAT Inhibition Reprograms T Cell Activation and Metabolism in Inflammatory Arthritis Patients

2025-11-27

Abstract excerpt

<title>Abstract</title> <p>Objectives: Inflammatory arthritis (IA) is a group of autoimmune diseases characterised by joint inflammation and progressive damage, thus impairing the patient’s quality of life. The JAK/STAT pathway inhibitor Tofacitinib has been successfully introduced into the clinic to treat patients with IA, however its direct effect on T cell responses is widely unknown. This study aims to assess...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
64b557a9-8caa-5b3a-94d5-7b1c816d8bf0
DOI
10.21203/rs.3.rs-8050605/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
JAK/STAT Inhibition Reprograms T Cell Activation and Metabolism in Inflammatory Arthritis PatientsDOI 10.21203/rs.3.rs-8050605/v1
Select a neighboring publication to make it the new centre.